Export

EN
FR
Dexamethasone
Essential medicine status
Section:
8. Immunomodulators and antineoplastics 8.2. Antineoplastics and supportive medicines 8.2.4. Hormones and antihormones
ATC codes: L01AA01
Indication
Plasma cell myeloma ICD11 code: 2A83.1
INN
Dexamethasone
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base
Oral > Solid > tablet: 4 mg (as dexamethasone base)
EML status history
First added in 2019 (TRS 1021)
Changed in 2025 (TRS 1064)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
Dexamethasone
DrugBank
Dexamethasone
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - to modify the listings to reflect the amount of dexamethasone in terms of dexamethasone salt or dexamethasone base.